Replimune
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 holds ✗
The FDA has granted accelerated approval to Replimune's melanoma drug Tudriqev following a yearlong regulatory clash.
9 sources
11 articles
v 8
38d ago
◼ Archived
Business
🔮 fades ✓
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 sources
2 articles
v 1
44d ago
◼ Archived
Business
🔮 holds ✗
Replimune shares surge following a favorable FDA advisory panel vote for its melanoma treatment.
12 sources
14 articles
v 12
45d ago
\n
\n
\n